Literature DB >> 32441683

Telegenetics: Remote Counseling During the COVID-19 Pandemic.

Suzanne M Mahon1.   

Abstract

During the COVID-19 pandemic, in-person provision of cancer genetic counseling and education services was not possible for a prolonged period. This article outlines why such services can continue remotely, despite the disruption of a pandemic, as well as describes the strengths and limitations of remote counseling to individuals and families about their hereditary risk for developing cancer. Considerations for the provision of remote counseling and some of the challenges of telehealth, with potential solutions, are described.

Entities:  

Keywords:  COVID-19; genetic counseling; genetics; remote delivery; telegenetics; telehealth

Mesh:

Year:  2020        PMID: 32441683     DOI: 10.1188/20.CJON.244-248

Source DB:  PubMed          Journal:  Clin J Oncol Nurs        ISSN: 1092-1095            Impact factor:   1.027


  4 in total

1.  The use of telemedicine in cardiogenetics clinical practice during the COVID-19 pandemic.

Authors:  Lusha W Liang; Isha Kalia; Farhana Latif; Marc P Waase; Yuichi J Shimada; Gabriel Sayer; Muredach P Reilly; Nir Uriel
Journal:  Mol Genet Genomic Med       Date:  2022-04-07       Impact factor: 2.473

2.  Remote vs in-person BRCA1/2 non-carriers test disclosure: patients' choice during Covid-19 pandemic restriction.

Authors:  Silvia Costanzo; Simona De Summa; Leonarda Maurmo; Maria Digennaro; Margherita Patruno; Angelo Paradiso
Journal:  Fam Cancer       Date:  2022-07-22       Impact factor: 2.446

3.  Sudden shift to remote genetic counseling during the COVID-19 pandemic: Experiences of genetics professionals in Italy.

Authors:  Daniela Turchetti; Linda Battistuzzi; Benedetta Bertonazzi; Lea Godino
Journal:  J Genet Couns       Date:  2021-06-06       Impact factor: 2.717

4.  Experiences from the epicenter: Professional impact of the COVID-19 pandemic on genetic counselors in New York.

Authors:  Katherine L Bergstrom; Tehilla E Brander; Kelsey E Breen; Hetanshi Naik
Journal:  Am J Med Genet C Semin Med Genet       Date:  2020-11-23       Impact factor: 3.359

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.